News

Apellis Pharmaceuticals Celebrates FDA Approval and Growth

Apellis Pharmaceuticals Celebrates FDA Approval and Growth

Great News for Apellis Pharmaceuticals

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is making waves in the biotechnology sector with recent achievements that highlight its expansion and commitment to innovation in therapeutic solutions. In the second quarter of 2025, the company reported significant financial results, accompanied by exciting news on regulatory approvals and product demand.

FDA Approval for EMPAVELI

Apellis recently received U.S. FDA approval for EMPAVELI (pegcetacoplan), which paves the way for treatment options for patients aged 12 and older afflicted with C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN). This approval underscores the company's dedication to addressing rare diseases through innovative research and development.

Royalty Purchase Agreement with Sobi

Another noteworthy milestone for Apellis was the announcement of a capped royalty purchase agreement with Sobi. This arrangement provides Apellis with up to $300 million for 90% of the ex-U.S. royalties of Aspaveli, another variation of pegcetacoplan. These funds will support continued growth and investment in the company's expanding pipeline.

Robust Financial Performance

In the second quarter of 2025, Apellis achieved remarkable financial results, generating a total revenue of $178 million. This figure includes $171 million from U.S. net product sales, reflecting a solid performance driven by strong demand for the company’s offerings.

Continued Growth of SYFOVRE

SYFOVRE (pegcetacoplan injection), another flagship product, continues to perform excellently, with quarter-over-quarter demand increasing by 6%. The U.S. net product revenue for SYFOVRE reached $151 million in the same period, solidifying its status as a market leader in addressing geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Advancements in Research and Upcoming Milestones

With the U.S. FDA approval in hand, Apellis is now turning its focus towards maximizing EMPAVELI's impact in treating C3G and IC-MPGN. The company is also preparing to initiate pivotal studies in delayed graft function (DGF) and focal segmental glomerulosclerosis (FSGS), both significant areas where the complement pathway plays a crucial role in disease progression.

Investing in Future Treatments

Apellis is committed to advancing its innovative research pipeline, which includes exciting projects like a one-time neonatal Fc receptor (FcRn) treatment utilizing cutting-edge gene editing technology.

Insights on Financial Health

As of June 30, 2025, Apellis reported a cash reserve of $370 million, alongside a positive outlook for supporting operations through existing cash, royalties from Sobi, and anticipated future product sales. This healthy cash position will play a vital role in the company’s journey towards sustainable profitability.

Leadership Updates

Recent changes in leadership include the appointment of Dr. Leslie Meltzer as chief research and development officer, effective August 25. Dr. Meltzer brings a wealth of experience in biopharmaceutical development and will be an asset to Apellis in navigating the complexities of drug approval and commercialization processes.

Frequently Asked Questions

What is EMPAVELI approved for?

EMPAVELI is approved for the treatment of C3 glomerulopathy and primary IC-MPGN in patients aged 12 and older.

How much revenue did Apellis generate in the second quarter of 2025?

Apellis generated a total revenue of $178 million in the second quarter of 2025.

What is SYFOVRE and its significance?

SYFOVRE is a pegcetacoplan injection approved for geographic atrophy, showing a strong market presence with $151 million in revenue.

Who is Apellis Pharmaceuticals' commercialization partner?

Apellis has a collaboration agreement with Sobi for the commercialization of Aspaveli and other therapies outside the U.S.

What is the outlook for Apellis Pharmaceuticals?

With strong financial health, FDA approvals, and innovative research initiatives, Apellis is set to continue its growth and potential market impact.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Voting for Future Urban Icons Begins Globally

Updated Category News Views 43

New Era for Urban Innovations Takes Center Stage Here's a twist folks didn't see coming: Future cities aren't just the stuff of sci-fi flicks anymore. We've got a global stage now—real, live, and buzzing with excitement from New Clark City in the Philippines. On October 31, 2026, they pulled back the curtain on 7wondersfc.com, flipping the switch on a worldwide voting...

Continue Reading
Alignment Healthcare Faces Investigation Over Alleged Fraud

Updated Category News Views 67

Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...

Continue Reading
Millrose Properties Faces Legal Storm: Investors Alerted

Updated Category News Views 166

Millrose Properties: A Storm's Brewing Whoa, step back and take a wide-eyed look at Millrose Properties—there’s a storm brewin’ and it’s a doozy! Right now, they’re up against one mighty class action lawsuit, and investors who’ve been hit for over $100k better circle December 8, 2026, on their calendars if they fancy a shot at lead plaintiff glory. We’re...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 173

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
SCANOLOGY's AirGO Pad Revolutionizes On-Site Inspections

Updated Category News Views 118

Mobile 3D Scanning — Finally, Some Real Innovation Gone are the days where engineers had to cart around bulky laptops just to finish a simple inspection. SCANOLOGY has thrown a real game-changer into the mix with their new AirGO Pad. It's essentially a slick tablet that keeps your scanning, inspecting, and reporting all in one place, right beside whatever tangled hunk...

Continue Reading
Wulcea Pioneers Safety in Smart Heated Apparel

Updated Category News Views 42

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

Continue Reading
PRTH Shareholder Concerns Amid Merger Investigation

Updated Category News Views 79

Behind Closed Doors: PRTH's Merger Drama Unfolds The market's got its share of tricky maneuvers and right now, Priority Technology Holdings, Inc. (NASDAQ:PRTH) is under the magnifying glass. Levi & Korsinsky, LLP has kicked off an investigation into the nitty-gritty of PRTH's acquisition by its largest shareholder—none other than their own Chairman and CEO, Thomas C....

Continue Reading
NIDS Aims Global with CES 2027, Boosts Sensor Supply

Updated Category News Views 170

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...

Continue Reading
Generational Happiness: Keio Study Shakes Norms

Updated Category News Views 69

Happiness Across Generations: New Light from Japan Think happiness is just a personal journey? Well, it turns out there's more to the story when you dive into family ties. A study from Keio University in Japan shakes things up by finding that happiness has a unique way of passing down from parent to child, showing a stronger grip across generations than general or mental...

Continue Reading
Sen. Collins Lauded for Transformative Kidney Care

Updated Category News Views 487

Steering Towards Innovation in Kidney Care In the world of political accolades, real achievements sometimes get buried beneath the pomp. But when the largest kidney patient group in the nation—AAKP, decides to honor Senator Susan M. Collins, it's not just another pat on the back. This one's got substance galore. Collins, a heavyweight on the U.S. Senate Committee on...

Continue Reading

Top 5 Most Recently Viewed Articles

Location Analytics Market Expected to Reach USD 58.05 Billion

Updated Category News Views 128

Insights into the Growing Location Analytics Market Location analytics is undoubtedly at the forefront of a technological revolution as businesses adapt to an increasingly interconnected world. With the rise of geospatial data, the importance of location-based insights has never been clearer. This growing demand for effective location intelligence solutions is reflected...

Continue Reading
RESAAS Enhances AI Features to Boost Commercial Data Exchange

Updated Category News Views 199

RESAAS Introduces Innovative AI Solutions for Growth RESAAS Services Inc. is making significant strides with its Commercial Data Exchange platform, known as CODE. The company has enhanced its technology with AI capabilities, leading to accelerated growth and expansion into new markets. These advancements signify a commitment to revolutionizing the real estate industry by...

Continue Reading
TFI International Announces Upcoming Financial Results Release

Updated Category News Views 62

TFI International's Financial Announcement TFI International Inc., a prominent player in the transportation and logistics sector in North America, has exciting news for its investors. The company is gearing up to announce its third-quarter financial results. This release will take place on a specified date that is after the markets close, ensuring that all stakeholders...

Continue Reading
Nigeria's Central Bank Adjusts Key Interest Rate to 27.50%

Updated Category News Views 483

Central Bank of Nigeria Increases Monetary Policy Rate The Central Bank of Nigeria has made a notable decision to increase the Monetary Policy Rate (MPR) by 250 basis points, raising it from 27.25% to 27.50%. This adjustment reflects the unanimous agreement reached by the Monetary Policy Committee (MPC). Maintaining Key Ratios for Financial Stability In conjunction with...

Continue Reading
Latest Updates from the Riksbank Bond Auctions and Insights

Updated Category News Views 225

Insights from Recent Riksbank Auctions on Government Bonds The recent auctions conducted by the Riksbank have provided valuable insights into the current state of government bonds. Investors closely monitor these events, as they reflect the market's sentiment and expectations. Let’s delve into the outcomes of the latest auctions, providing a clearer understanding of...

Continue Reading